Top

Published in:

01-07-2009 | Case report

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

Authors: Roy Torcuator, Richard Zuniga, Randa Loutfi, Tom Mikkelsen

Published in: Journal of Neuro-Oncology | Issue 3/2009

Abstract

Diffuse brainstem glioma carries a dismal prognosis. The current cornerstone of treatment is radiation therapy. Chemotherapy appears to be ineffective and the role of this treatment in the recurrent or progressive setting is not known. Bevacizumab and irinotecan have been reported to have shown radiographic response and improvement in progression-free survival among patients with malignant supratentorial gliomas. In this paper, we report our experience in an adult patient with progressive diffuse brainstem glioma treated with bevacizumab and irinotecan.

Packer RJ (1999) Brain tumors in children. Arch Neurol 56(4):421–425. doi:10.1001/archneur.56.4.421 PubMedCrossRef

Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40(2):265–271. doi:10.1016/S0360-3016(97)00572-5 PubMed

Rubin G, Michowitz S, Horev G, Herscovici Z, Cohen IJ, Shuper A, Rappaport ZH (1998) Pediatric brain stem gliomas: an update. Childs Nerv Syst 14(4–5):167–173. doi:10.1007/s003810050205 PubMedCrossRef

Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY, Association des Neuro-Oncoloques d’Expression Francoise (ANOCEF) (2001) Brainstem gliomas in adults: prognostic factors and classification. Brain 124(Pt 12):2528–2539. doi:10.1093/brain/124.12.2528 PubMedCrossRef

Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziam M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gondola L (2008) Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87(3):355–361. doi:10.1007/s11060-008-9525-5 PubMedCrossRef

Landolfi JC, Thaler HT, DeAngelis LM (1998) Adult brainstem gliomas. Neurology 51(4):1136–1139PubMed

Selvapandian S, Rajshekhar V, Chandy MJ (1999) Brainstem glioma: comparative study of clinico-radiological presentation, pathology and outcome in children and adults. Acta Neurochir (Wien) 141(7):721–726. doi:10.1007/s007010050367 (discussion 726–727)CrossRef

Epstein F, Constantini S (1996) Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 24(1):24–34. doi:10.1159/000121011 PubMedCrossRef

Schild SE, Stafford SL, Brown PD, Wood CP, Scheithauer BW, Schombert PJ, Wong WW, Lyons MK, Shaw EG (1998) The results of radiotherapy for brainstem tumors. J Neurooncol 40(2):171–177. doi:10.1023/A:1006193306286 PubMedCrossRef

10.

Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15(10):545–553. doi:10.1007/s003810050542 PubMedCrossRef

11.

Shuper A, Kornreich L, Loven D, Michowitz S, Schwartz M, Cohen IJ (1998) Diffuse brain stem gliomas. Are we improving outcome? Childs Nerv Syst 14(10):578–581. doi:10.1007/s003810050275 PubMedCrossRef

12.

Bouffet E, Khelfaoui F, Philip I, Biron P, Brunet-Mentigny M, Philip T (1997) High-dose carmustine for high-grade gliomas in childhood. Cancer Chemother Pharmacol 39(4):376–379. doi:10.1007/s002800050586 PubMedCrossRef

13.

Allen JC, Siffert J (1996) Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg 24(2):98–102. doi:10.1159/000121024 PubMedCrossRef

14.

Wolff JE, Westphal S, Molenkamp G, Gnekow A, Warmuth-Metz M, Rating D, Kuehl J (2002) Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 87(9):945–949. doi:10.1038/sj.bjc.6600552 PubMedCrossRef

15.

Vredenburgh JJ, Desjardins A, Herndon JEII, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathosumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13(4):1253–1259. doi:10.1158/1078-0432.CCR-06-2309 PubMedCrossRef

16.

Vredenburgh JJ, Desjardins A, Herndon JEII, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathosumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30):4722–4729. doi:10.1200/JCO.2007.12.2440 PubMedCrossRef

17.

Cloughesy TF, Prados MD, Wen PY, Mikkelsen T, Abrey LE, hiff D, Yung WK, Maoxia Z, Dimery I, Friedman HS (2008) A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM). J Clin Oncol 26:91s (abstr 2010b)

18.

Gururangan S, Chi S, Onar A, Packer R, Young Poussaint T, Gilbertson R, Friedman H, Kun L, Boyett J (2008) Phase II study of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma—a Pediatric Brain Consortium Study (PBTC-022). Neuro Oncol 5:833 (abstract MA-63)

19.

Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197–206. doi:10.1634/theoncologist.9-2-197 PubMedCrossRef

20.

Lu C, Shervington A (2008) Chemoresistance in gliomas. Mol Cell Biochem 312:71–80. doi:10.1007/s11010-008-9722-8 PubMedCrossRef

21.

Reddy A, Mapstone T (2000) Brain stem tumors. In: Bernstein M, Berger MS (eds) Neuro-oncology the essentials. Thieme Medical Publishers, Inc, New York, pp 352–386

22.

Packer RJ, Prados M, Phillips P, Nicholson HS, Bovett JM, Goldwein J, Rorke LB, Needle MN, Sutton L, Zimmerman RA, Fitz CR, Vezina LG, Etcubanas E, Wallenberg JC, Reaman G, Wara W (1996) Treatment of children with newly diagnosed brainstem gliomas with intravenous recombinant beta-inteferon and hyperfractionated radiation therapy: a Childrens Cancer Group phase I/II study. Cancer 77:2150–2156. doi:10.1002/(SICI)1097-0142(19960515)77:10<2150::AID-CNCR28>3.0.CO;2-TPubMedCrossRef

23.

Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goulmnerova L, Billett AL, Kieran M, Tarbell NJ (2003) A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys 55(5):1182–1185. doi:10.1016/S0360-3016(02)04391-2 PubMed

24.

Findlay JL, Zacharoulis S (2005) The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical- and futuristic-perspective. J Neurooncol 75:253–266. doi:10.1007/s11060-005-6747-7 CrossRef

25.

Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumors. Nat Rev Neurosci 8(8):610–622. doi:10.1038/nrn2175 PubMedCrossRef

26.

Jain RK (2005) Antiangiogenic therapy for cancer: current and emerging concepts. Oncology 19(4(Suppl 3)):7–16 (Williston Park)PubMed

Title: Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report
Authors: Roy Torcuator
Richard Zuniga
Randa Loutfi
Tom Mikkelsen
Publication date: 01-07-2009
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2009
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-008-9782-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study

miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors

Primary CNS lymphoma presenting as fever of unknown origin

Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction

Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients

Coincidence of central neurocytoma and multiple glioblastomas: a rare case report